{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:37:21Z","timestamp":1789879041077,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T00:00:00Z","timestamp":1281052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Wellcome Trust","award":["WT079838"],"award-info":[{"award-number":["WT079838"]}]},{"name":"Wellcome Trust","award":["WT077705"],"award-info":[{"award-number":["WT077705"]}]},{"name":"Wellcome Trust","award":["WT083481"],"award-info":[{"award-number":["WT083481"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.bcp.2010.07.038","type":"journal-article","created":{"date-parts":[[2010,8,8]],"date-time":"2010-08-08T08:37:25Z","timestamp":1281256645000},"page":"1478-1486","source":"Crossref","is-referenced-by-count":67,"title":["Identification of a \u03ba-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis"],"prefix":"10.1016","volume":"80","author":[{"given":"Deuan C.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hallyburton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laste","family":"Stojanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Frearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Fairlamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.07.038_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pt.2006.06.011","article-title":"Human African trypanosomiasis: connecting parasite and host genetics","volume":"22","author":"Garcia","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2010.07.038_bib0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio837","article-title":"Drug discovery and development for neglected parasitic diseases","volume":"2","author":"Renslo","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"P\u00e9pin","year":"1994","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox\u2013eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2010.07.038_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"Thuita","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.bcp.2010.07.038_bib0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pt.2007.08.019","article-title":"Target assessment for antiparasitic drug discovery","volume":"23","author":"Frearson","year":"2007","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1747-0285.2006.00389.x","article-title":"Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei","volume":"67","author":"Mackey","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bcp.2010.07.038_bib0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J Parasitol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bcp.2010.07.038_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue\u00ae assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro","volume":"68","author":"Raz","year":"1997","journal-title":"Acta Trop"},{"key":"10.1016\/j.bcp.2010.07.038_bib0070","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O\u2019Brien","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2010.07.038_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2006.09.003","article-title":"Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960\u20131995 and 1999\u20132004","volume":"100","author":"Likeufack","year":"2006","journal-title":"Acta Trop"},{"key":"10.1016\/j.bcp.2010.07.038_bib0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4269\/ajtmh.1989.40.487","article-title":"Physiological activation of the mitochondrion and the transformation capacity of DFMO induced intermediate and short stumpy bloodstream form trypanosomes","volume":"40","author":"Giffin","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bcp.2010.07.038_bib0085","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.038_bib0090","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2010.07.038_bib0095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260110607","article-title":"Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var caesius","volume":"11","author":"Arcamone","year":"1969","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.bcp.2010.07.038_bib0100","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/AAC.01418-06","article-title":"Bis-acridines as lead anti-parasitic agents: structure activity analysis of a discrete compound library in vitro","volume":"51","author":"Caffrey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2010.07.038_bib0105","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm990946n","article-title":"Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): influence of the linker","volume":"43","author":"Girault","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.07.038_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exppara.2006.05.002","article-title":"Plasmodium berghei: in vitro and in vivo activity of dequalinium","volume":"115","author":"Rodrigues","year":"2007","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0003-9861(58)90383-7","article-title":"Antibiotics as tools for metabolic studies. I. A survey of toxic antibiotics in respiratory, phosphorylative and glycolytic systems","volume":"78","author":"Lardy","year":"1958","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2010.07.038_bib0120","first-page":"2741","article-title":"Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro","volume":"45","author":"Jordan","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.038_bib0125","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.07.038_bib0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S0031182004005906","article-title":"Human infectivity trait in Trypanosoma brucei: stability, heritability and relationship to sra expression","volume":"129","author":"Turner","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.bcp.2010.07.038_bib0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2958.2008.06305.x","article-title":"Chemical and genetic validation of dihydrofolate reductase\u2013thymidylate synthase as a drug target in African trypanosomes","volume":"69","author":"Sienkiewicz","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bcp.2010.07.038_bib0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2010.07.038_bib0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)33422-1","article-title":"U-50,488\u2014a selective and structurally novel non-mu-(kappa) opioid agonist","volume":"224","author":"Vonvoigtlander","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.07.038_bib0150","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.07.038_bib0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pt.2007.04.013","article-title":"Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum","volume":"23","author":"Sanchez","year":"2007","journal-title":"Trends Parasitol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210005769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210005769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T23:10:36Z","timestamp":1740352236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0006295210005769"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.07.038","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}